Immunotherapy is the type of treatment that helps immune system to fight cancer. The immune system helps body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.

Immunotherapy is a type of biological therapy, is involves modification of patients own immune cells using biotechnology for treating cancer. There are various types of immunotherapies depending on the cells or cellular components modified and the molecules targeted in cancer cells. They include T cells, macrophages, specific receptors, proteins, chemical mediators and enzymes involved in immune response towards neoplasm. Hence immunotherapy is a much more specific and targeted therapy for cancer. A high therapeutic potential with minimum adverse effects and tumor specificity with no harm to normal body cells makes this therapy different than the preexisting ones. Immunotherapy will thus prove to be a major tool to combat all types of cancer.

 Immunotherapy often uses substances referred to as biological response modifiers (BRMs). The body usually only produces small amounts of these BRMS in response to infection or disease; however, in the laboratory, large amounts of these BRMs can be generated in order to provide therapy for cancer, rheumatoid arthritis, and other illnesses.

One immune system response to foreign bodies is to produce large amounts of antibodies. These antibodies recognize and stick to certain proteins, also known as antigens, that are found on foreign bodies. Once bound to the antigens, antibodies recruit other immune system components to attack and destroy any cell that has the antigen.

Researchers can now generate antibodies that target one antigen in particular, such as one presented by cancer cells. These antibodies are called monoclonal antibodies and scientists can produce many copies of them in the laboratory once they have identified the correct antigen to target.

Journal of Immunological Disorders and Immunotherapy (ISSN: 2593-8509) is a scholarly journal maintains high standards of scientific excellence and its editorial board ensures a rapid peer review process with the help of Editorial Tracking System. Editorial Tracking is an online manuscript submission, review and tracking systems used by most of the best open access journals. Review processing is performed by the editorial board members of journal or outside experts; at least two independent reviewers approval followed by editor's approval is required for acceptance of any citable manuscript. Abstracts and full texts of all articles published by the Immunological Disorders and Immunotherapy Open Access Journal are freely accessible to everyone immediately after publication.
Authors are requested to submit manuscripts online or send as an e-mail attachment to the Editorial Office at editor@longdom.org.